Expression and Underlying Roles of IGFBP-3 in Paclitaxel-Treated Gastric Cancer Sgc-7901 Cells |
Huang, Gang
(Gansu Provincial Hospital)
Dang, Zhong-Feng (The Tumor Hospital of Gansu Province) Dang, Ya-Mei (Gansu Provincial Hospital) Cai, Wei (Gansu Provincial Hospital) Li, Yuan (Gansu Provincial Hospital) Chen, Yi-Rong (Gansu Provincial Hospital) Xie, Xiao-Dong (School of Basic Medical Sciences, Lanzhou University) |
1 | Adams JM, S Cory (1998). The Bcl-2 protein family: arbiters of cell survival. Science, 281, 1322-6. DOI ScienceOn |
2 | Alami N, V Page, Q Yu, et al (2008). Recombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer models. Growth Horm IGF Res, 18, 487-96. DOI |
3 | Biernacka KM, CC Uzoh, L Zeng, et al (2013). Hyperglycaemiainduced chemoresistance of prostate cancer cells due to IGFBP2. Endocr Relat Cancer, 20, 741-51. DOI |
4 | Cortes-Sempere M, MP de Miguel, O Pernia, et al (2013). IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/ Akt pathway in non-small cell lung cancer. Oncogene, 32, 1274-83. DOI |
5 | Dang YM, Huang G, Chen YR, et al (2014). Sulforaphane inhibits the proliferation of the BIU87 bladder cancer cell line via IGFBP-3 elevation. Asian Pac J Cancer Prev. 15, 1517-20. 과학기술학회마을 DOI |
6 | Duggan C, CY Wang, ML Neuhouser, et al (2013). Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer. Int J Cancer, 132, 1191-200. DOI |
7 | Eichhorn JM, SE Alford, N Sakurikar, et al (2014). Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survival. Exp Cell Res, 322, 415-24. DOI |
8 | Foulstone EJ, L Zeng, CM Perks, et al (2013). Insulin-like growth factor binding protein 2 (IGFBP-2) promotes growth and survival of breast epithelial cells: novel regulation of the estrogen receptor. Endocrinology, 154, 1780-93. DOI |
9 | Holdaway IM, BH Mason, AE Lethaby, et al (2003). Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer. ANZ J Surg, 73, 905-8. DOI ScienceOn |
10 | Liang PI, YH Wang, TF Wu, et al (2013). IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder. J Clin Pathol, 66, 573-82. DOI |
11 | Kiyoshima T, H Yoshida, H Wada, et al (2013). Chemoresistance to concanamycin A1 in human oral squamous cell carcinoma is attenuated by an HDAC inhibitor partly via suppression of Bcl-2 expression. PLoS One, 8, 80998. DOI |
12 | Koyama S, LJ Cobb, HH Mehta, et al (2010). Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis. Growth Horm IGF Res, 20, 55-62. DOI |
13 | Kalluri HS, RJ Dempsey (2011). IGFBP-3 inhibits the proliferation of neural progenitor cells. Neurochem Res, 36, 406-11. DOI |
14 | Williams AC, H Smartt, HZ AM, et al (2007). Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-kappaB. Cell Death Differ, 14, 137-45. DOI ScienceOn |
15 | Peters I, I Tossidou, J Achenbach, et al (2006). IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes. J Am Soc Nephrol, 17, 1644-56. DOI |
16 | Kang WK, I Lee, U Ko, et al (2005). Differential effects of RhoA signaling on anticancer agent-induced cell death. Oncol Rep, 13, 299-304. |
17 | Soubry A, D Il'yasova, R Sedjo, et al (2012). Increase in circulating levels of IGF-1 and IGF-1/IGFBP-3 molar ratio over a decade is associated with colorectal adenomatous polyps. Int J Cancer, 131, 512-7. DOI |
18 | Sunderic M, B Dukanovic, V Malenkovic, et al (2014). Molecular forms of the insulin-like growth factor-binding protein-2 in patients with colorectal cancer. Exp Mol Pathol, 96, 48-53. DOI |
19 | Vallon M, C Seidl, B Blechert, et al (2012). Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest. Eur J Nucl Med Mol Imaging, 39, 1886-97. DOI |
20 | Wang X, JJ Beitler, H Wang, et al (2014). Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis. PLoS One, 9, 86369. DOI |
21 | Zhang GJ, Z Zhang (2013). Effect of Bcl-2 on apoptosis and transcription factor NF-kappaB activation induced by adriamycin in bladder carcinoma BIU87 cells. Asian Pac J Cancer Prev, 14, 2387-91. 과학기술학회마을 DOI ScienceOn |
22 | Zeng L, C Jarrett, K Brown, et al (2013). Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the antitumorigenic effects of 5-Aza-2'-deoxycytidine (AZA) in breast cancer cells. Exp Cell Res, 319, 2282-95. DOI |
23 | Hossein G, Keshavarz M, Ahmadi S, et al (2012). Synergistic effects of PectaSol-C modified citrus pectin an inhibitor of galectin-3 and paclitaxel on apoptosis of human SKOV-3 ovarian cancer cells. Asian Pac J Cancer Prev, 14, 7561-8. 과학기술학회마을 DOI ScienceOn |